期刊文献+

宫颈脱落细胞病变中HPV L1蛋白的表达及临床意义 被引量:4

Expression of HPV L1 Protein in Exfoliated Cervical Cells and its Clinical Significance
暂未订购
导出
摘要 目的探讨HPV L1蛋白在宫颈脱落细胞病变中的表达情况及其临床意义。方法以非同位素标记核酸分子杂交技术和免疫组织/细胞化学技术为基础,在同时采用核酸和免疫水平双重检测传染病病原体人乳头瘤病毒壳蛋白抗体(HPV L1)的方法对124例妇科宫颈脱落细胞TCT标本进行HPV L1蛋白检测。结果 HPV L1蛋白的总阳性率为44.35%(55/124)。其中轻度炎症的阳性率为66.67%(26/39);中度炎症的阳性率为41.94%(13/31);重度炎症的阳性率为37.50%(6/16);低级别上皮内瘤变的阳性率为30.43%(7/23);高级别上皮内瘤变的阳性率为20.00%(3/15)。HPV L1蛋白在轻度炎症的阳性表达率高于中度炎症和重度炎症,明显高于低级别上皮内瘤变和高级别上皮内瘤变,差异具有统计学意义(χ2=13.65,P<0.05)。结论 HPV L1蛋白的阳性表达与宫颈脱落细胞病变的类型密切相关,随着宫颈脱落细胞病变的加深,HPV L1蛋白的阳性率逐渐减弱,HPV L1蛋白的丢失可能是宫颈病变进展的一个早期事件,HPV L1蛋白的阳性表达与宫颈病变的生物学行为密接相关,可作为宫颈病变治疗预后的可靠理论依据。 Objective To determine the expression of HPV L1 protein in exfoliated cervical cells and discuss its clinical significance.Methods The expression of HPV L1 protein in cervical tissue Thinprep cytology test(TCT) specimens of 124 patients were detected by using isotope labeling nucleic acid molecular hybridization and immune tissue/cell chemical technology.Results The total positive rate of HPV L1 protein in exfoliated cervical cells was 44.35%(55/124).The positive rate in mild inflammation was 66.67%(26/39),in the moderate inflammation was 41.94%(13/31),in the severe inflammation was 37.50%(6/16),in low-grade intraepithelial neoplasia was 30.43%(7/23),in high-grade intraepithelial neoplasia was 20%(3/15).The positive rate in the mild inflammation was higher than that in moderate and severe inflammation,and was much higher than that in low-and high-grade intraepithelial neoplasia(χ2=13.65,P0.05),the difference was statistical significant.Conclusion The positive expression of HPV L1 protein was closely related to the lesions types of exfoliated cervical cells.With the deepening of cervical lesions,the positive rate of HPV L1 protein decreased gradually.The loss of HPV L1 protein may be an early event of the cervical lesions progress.The positive rate of HPV L1 protein was correlated with its biological behavior of cervical lesion.It can be used as cervical lesion treatment outcome and reliable theoretical basis.
作者 杨红
出处 《中华全科医学》 2013年第3期394-395,F0003,共3页 Chinese Journal of General Practice
关键词 宫颈脱落细胞病变 HPVL1蛋白 核酸和免疫水平双重检测 Exfoliated cervical cells Lesions of the cervix HPV L1 protein Nucleic acids hybridization Immunohistochemistry
  • 相关文献

参考文献10

二级参考文献49

  • 1Keng-Ling Wallin, Fredrik Wiklund, M. Sc, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer[ J ]. Journal of Practical Oncology, 1999,341 : 1633-1638.
  • 2Wolfgang Eppel, Cbfistof Worda, Peter Frigo, et al. Human papillomavirus in the cervix and placenta obstetrics [ J ]. Gynecology, 2000,96 : 337-341.
  • 3Obert D, Burk, Masanori, et al. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix [ J ]. Cancer Research,2003,63 : 7215-7220.
  • 4Bram Ter Harmsel, Frank Smedts, John Kuijpers, et al. Relationship between human papillomavirus type 16 in the cervix and intraepithelial neoplasia [ J ]. Obstetrics & Gynecology, 1999,93:46 -50.
  • 5Helland A,Borresen AL,Ristensen GK,et al. DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix:relationship to human papillomavirus infection and prognosis Cancer Epidemiology Biomarkers [ J ]. Biomarkers & Prevention,2003,3:479 -486.
  • 6Mandelblatt, William F. Lawrence Costs and benefits of different strategies to screen for cervical cancer in less-developed countries[J]. Journal of the National Cancer Institute,2002,94(19) :1469-1483.
  • 7Melsheimer Peter, Svetlana Vinokurova. DNA aneuploidy and integratio of human papillomavirus type 16 E6/E7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri [ J ]. Clinical Cancer Research,2004,10:3059-3063.
  • 8McMurray HR, Nguyen D, Westbrook TF, et al. Biology of human papillomavirus[J]. Int J Exp Pathol, 2001, 82 ( 1 ) : 15-33.
  • 9Yoshida T, Sano T, Kanuma T, et al. Immunochemieal analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions [ J ]. Cancer, 2008, 114 ( 2 ) :83 -88.
  • 10Arafa M, Boniver J, Delvenne P. Detection of HPV-induced cervical (pre) neoplastic lesions : a tissue microarray (TMA) study[ J ]. Appl Immunohistochem Mol Morphol, 2008, 16(5) : 422-432.

共引文献26

同被引文献44

  • 1Day PM,Kines RC,Thompson CD,etal.In vivo mechanisms of vaccine-induced protection against HPV infection[J].Cell Host Microbe,2010,8(3):260-270.
  • 2Duby JM,DiFurio MJ.Implementation of the ThinPrep Imaging System in a tertiary military medical center[J].Cancer,2009,117(4):264-270.
  • 3Seheurer ME, Tortolero-Luna G, Adler-Storthz K. Human papillomavirus infection : biology, epidemiology, and prevention [J]. Int J Gynecol Cancer, 2005, 15 (5) : 727-746.
  • 4XIAO W, BIAN ML, MA L, et al. Immunochemical analysis of human papillomavirus L1 capsid protein in Liquid-Based cytology samples from cervical lesions [J]. Acta Cytol, 2010, 54 (5) : 661-667.
  • 5YU L, WANG L, ZHONG J, et al. Diagnostic value of pI6INK4A, Ki-67, and human papillomavirus L1 capsid protein immunoehemical staining on cell blocks from residuak liquid-based gynecologic cytology specimens [ J ]. Cancer Cytopathol, 2010, 118 (1) : 47-55.
  • 6Griesser H, Sander H, Hilfrich R, et al. Correlation of immnochemieal detection of HPV L1 eapsid protein in pap smears with regression of high-risk HPV positive mild/moderate dysplasia [J]. Anal Quant Cytol Histol. 2004, 26 (5) : 241-245.
  • 7成志强,王晓玫,蔡进中,单军,高利昆,许静,彭全洲,胡锦涛.原位杂交检测宫颈活检组织HPV感染的临床意义[J].中华全科医学,2010,8(2):148-149. 被引量:3
  • 8陈仲波,朱笕青,俞华,牟翰舟,吕卫国.1169例宫颈癌患者人乳头状瘤病毒感染状况分析[J].中华医院感染学杂志,2010,20(6):809-811. 被引量:39
  • 9李茜,卞美璐.人端粒酶RNA组分基因检测在宫颈病变中的应用[J].中日友好医院学报,2010,24(1):11-14. 被引量:1
  • 10郝敏,卞美璐.人乳头瘤病毒L1蛋白功能及其临床应用[J].中国实用妇科与产科杂志,2010,26(5):352-355. 被引量:17

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部